(MDB) MongoDB - Ratings and Ratios
Database, Cloud, Enterprise, Community, Services
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 56.3% |
| Value at Risk 5%th | 75.2% |
| Relative Tail Risk | -18.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 42.14 |
| CAGR/Max DD | 0.42 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.584 |
| Beta | 1.589 |
| Beta Downside | 1.728 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.88% |
| Mean DD | 30.78% |
| Median DD | 30.59% |
Description: MDB MongoDB December 17, 2025
MongoDB, Inc. (NASDAQ:MDB) offers a general-purpose, document-oriented database platform that is delivered through three primary products: MongoDB Atlas (a fully managed, multi-cloud DBaaS), MongoDB Enterprise Advanced (a commercial server for on-premises, cloud, or hybrid deployments), and the free Community Server edition that serves as an entry point for developers. The company also monetizes professional services such as consulting and training.
For fiscal year 2024, MongoDB reported revenue of approximately $1.6 billion, representing a 20% year-over-year increase, and its annual recurring revenue (ARR) grew to about $2.4 billion, reflecting strong customer expansion and higher subscription uptake. Gross margins remained in the low-70% range, consistent with the high-margin nature of software-as-a-service businesses. The firm’s free-tier conversion rate-customers moving from Community Server to paid Atlas subscriptions-stood at roughly 12%, a key lever for future growth.
The database market is being reshaped by accelerating cloud migration, the rise of multi-cloud strategies, and increasing data-intensive workloads from generative AI applications. These macro trends boost demand for flexible, scalable, and developer-friendly platforms like MongoDB, while also intensifying competition from rivals such as Amazon Aurora, Microsoft Azure Cosmos DB, and Snowflake.
For a deeper, data-driven assessment of MDB’s valuation dynamics, consider exploring ValueRay’s analytical toolkit.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-70.9m TTM) > 0 and > 6% of Revenue (6% = 139.0m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 5.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 102.5% (prev 60.20%; Δ 42.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 384.4m > Net Income -70.9m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 5.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (81.2m) change vs 12m ago 9.76% (target <= -2.0% for YES) |
| Gross Margin 71.62% (prev 73.72%; Δ -2.10pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 68.24% (prev 59.42%; Δ 8.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -9.95 (EBITDA TTM -32.5m / Interest Expense TTM 6.71m) >= 6 (WARN >= 3) |
Altman Z'' -0.49
| (A) 0.67 = (Total Current Assets 2.93b - Total Current Liabilities 558.0m) / Total Assets 3.57b |
| (B) -0.54 = Retained Earnings (Balance) -1.93b / Total Assets 3.57b |
| (C) -0.02 = EBIT TTM -66.8m / Avg Total Assets 3.40b |
| (D) -2.83 = Book Value of Equity -1.92b / Total Liabilities 678.2m |
| Total Rating: -0.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.17
| 1. Piotroski 3.0pt |
| 2. FCF Yield 1.12% |
| 3. FCF Margin 15.30% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda 24.58 |
| 6. ROIC - WACC (= -21.36)% |
| 7. RoE -2.43% |
| 8. Rev. Trend 98.72% |
| 9. EPS Trend 85.68% |
What is the price of MDB shares?
Over the past week, the price has changed by +1.14%, over one month by +25.85%, over three months by +34.43% and over the past year by +68.28%.
Is MDB a buy, sell or hold?
- Strong Buy: 19
- Buy: 9
- Hold: 12
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MDB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 440.1 | 3.5% |
| Analysts Target Price | 440.1 | 3.5% |
| ValueRay Target Price | 466.8 | 9.8% |
MDB Fundamental Data Overview December 17, 2025
P/E Forward = 74.0741
P/S = 14.6125
P/B = 11.8068
P/EG = 1.6716
Beta = 1.454
Revenue TTM = 2.32b USD
EBIT TTM = -66.8m USD
EBITDA TTM = -32.5m USD
Long Term Debt = 34.6m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 9.14m USD (from shortTermDebt, last quarter)
Debt = 34.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -799.5m USD (from netDebt column, last quarter)
Enterprise Value = 31.59b USD (33.86b + Debt 34.6m - CCE 2.31b)
Interest Coverage Ratio = -9.95 (Ebit TTM -66.8m / Interest Expense TTM 6.71m)
FCF Yield = 1.12% (FCF TTM 354.6m / Enterprise Value 31.59b)
FCF Margin = 15.30% (FCF TTM 354.6m / Revenue TTM 2.32b)
Net Margin = -3.06% (Net Income TTM -70.9m / Revenue TTM 2.32b)
Gross Margin = 71.62% ((Revenue TTM 2.32b - Cost of Revenue TTM 657.7m) / Revenue TTM)
Gross Margin QoQ = 71.48% (prev 71.01%)
Tobins Q-Ratio = 8.86 (Enterprise Value 31.59b / Total Assets 3.57b)
Interest Expense / Debt = 7.33% (Interest Expense 2.54m / Debt 34.6m)
Taxrate = 248.7% (out of range, set to none) (3.36m / 1.35m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 5.25 (Total Current Assets 2.93b / Total Current Liabilities 558.0m)
Debt / Equity = 0.01 (Debt 34.6m / totalStockholderEquity, last quarter 2.89b)
Debt / EBITDA = 24.58 (negative EBITDA) (Net Debt -799.5m / EBITDA -32.5m)
Debt / FCF = -2.25 (Net Debt -799.5m / FCF TTM 354.6m)
Total Stockholder Equity = 2.91b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.99% (Net Income -70.9m / Total Assets 3.57b)
RoE = -2.43% (Net Income TTM -70.9m / Total Stockholder Equity 2.91b)
RoCE = -2.27% (EBIT -66.8m / Capital Employed (Equity 2.91b + L.T.Debt 34.6m))
RoIC = -9.50% (negative operating profit) (EBIT -66.8m / (Assets 3.57b - Curr.Liab 558.0m - Cash 2.31b))
WACC = 11.86% (E(33.86b)/V(33.89b) * Re(11.87%) + (debt cost/tax rate unavailable))
Discount Rate = 11.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.55%
[DCF Debug] Terminal Value 70.01% ; FCFE base≈271.9m ; Y1≈335.5m ; Y5≈572.4m
Fair Price DCF = 66.57 (DCF Value 5.42b / Shares Outstanding 81.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 85.68 | EPS CAGR: 70.94% | SUE: 3.58 | # QB: 13
Revenue Correlation: 98.72 | Revenue CAGR: 25.70% | SUE: 3.78 | # QB: 17
EPS next Quarter (2026-04-30): EPS=1.20 | Chg30d=+0.226 | Revisions Net=+28 | Analysts=29
EPS next Year (2027-01-31): EPS=5.55 | Chg30d=+1.199 | Revisions Net=+37 | Growth EPS=+15.2% | Growth Revenue=+18.1%
Additional Sources for MDB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle